+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022



Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022



International Journal of Radiation Oncology, Biology, Physics 82(1): 492; Author Reply 492




(PDF emailed within 0-6 h: $19.90)

Accession: 055260496

Download citation: RISBibTeXText

PMID: 22182718

DOI: 10.1016/j.ijrobp.2011.08.042


Related references

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 80(4): 1015-1022, 2011

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 72(4): 967-971, 2008

In regard to Gopal et al. ACR appropriateness criteria on induction and adjuvant therapy for stage N2 non-small-cell lung cancer: expert panel on radiation oncology-lung (Int J Radiat Oncol Biol Phys 2010;78:969-974). International Journal of Radiation Oncology, Biology, Physics 81(5): 1592-1593, 2012

Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency (Int J Radiat Oncol Biol Phys 2011;79:660-669). International Journal of Radiation Oncology, Biology, Physics 82(2): 521; Author Reply 521-521; Author Reply 521, 2012

Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052). International Journal of Radiation Oncology, Biology, Physics 66(4): 1273-4; Author Reply 1274, 2006

In regard to "Dose escalation in the radiation therapy of prostate cancer" (Int J Radiat Oncol Biol Phys 2011;80:1289-1291). International Journal of Radiation Oncology, Biology, Physics 82(4): 1317-1318, 2012

Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). International Journal of Clinical Oncology 22(5): 849-856, 2017

Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases. International Journal of Radiation Oncology, Biology, Physics 81(3): 856-862, 2011

In regards to Chen et al.: Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma (Int J Radiat Oncol Biol Phys 2006;66:1408-1414). International Journal of Radiation Oncology, Biology, Physics 68(5): 1584-5; Author Reply 1585, 2007

Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209). International Journal of Radiation Oncology, Biology, Physics 58(5): 1636; Author Reply 1636-7, 2004

In regard to Bogart et al.: 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage non-small-cell lung cancer: Analysis of cancer and leukemia group B study 39808 (Int J Radiat Oncol Biol Phys 2004;59:460-468). International Journal of Radiation Oncology, Biology, Physics 60(5): 1661-2; Author Reply 1662-3, 2004

Reporting of true spinal cord dose is encouraged for stereotactic body radiation therapy for spinal tumors. In regard to Sahgal et al. (Int J Radiat Oncol Biol Phys 2010;77:548-553). International Journal of Radiation Oncology, Biology, Physics 78(1): 314; Author Reply 314-314; Author Reply 314, 2010

Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387). International Journal of Radiation Oncology, Biology, Physics 60(4): 1339; Author Reply 1339-40, 2004

Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271). International Journal of Radiation Oncology, Biology, Physics 71(3): 958-959, 2008

Stereotactic radiosurgery for vestibular schwannomas: in regard to Kapoor et al. (Int J Radiat Oncol Biol Phys 2011;81:647-653). International Journal of Radiation Oncology, Biology, Physics 82(4): 1324-1324, 2012